• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ADHD:US

15.5200 USD 0.8900 6.08%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Alcobra Ltd (ADHD)

Open: 14.9500 Day's Range: 14.9500 - 16.0540 Volume: 81,904
Previous Close: 14.6300 52wk Range: 6.5000 - 26.9600 1-Yr Rtn: -

Stock Chart for ADHD

No chart data available.
  • ADHD:US 15.5200
  • 1D
  • 1M
  • 1Y
14.6300
Interactive ADHD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADHD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9150
Est. PEG Ratio -
Market Cap (M USD) 211.64
Shares Outstanding (M) 13.64
30 Day Average Volume 96,656
Price/Book (mrq) 4.3469
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADHD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ADHD

Alcobra Ltd. operates as a biopharmaceutical company. The Company develops a patented, non-stimulant pharmaceutical drug designed to treat Attention Deficit Hyperactivity Disorder. Alcobra provides its products to the medical and pharmaceutical industries.

Aharon SchwartzChairmanYaron DanielyPresident/CEO
Ehud Moshe Gilboa "Udi"CFO/Chief Acctg Officer
More Company Profile & Key Executives for ADHD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil